Drug firm, Aurobindo Pharma has reported consolidated net loss of Rs 28.54 crore for the quarter ended December 31, 2011, against net profit of Rs 188.63 crore for the corresponding period last fiscal. The group’s consolidated net sales rose by 7.74% to Rs 1,284.51 crore during the quarter under review from Rs 1,192.20 crore in the year-ago period.
On a standalone basis, the company posted a net profit of Rs 12.93 crore for the third quarter ended December 31, 2011, as against Rs 183.85 crore in the same period last fiscal. Net sales rose by 3.88% to Rs 1,201.50 crore during the quarter under review from Rs 1,156.61 crore in the year-ago period.
